Hyperbaric oxygen treatment for severe brain injury
Official title: Hyperbaric Oxygen Brain Injury Treatment (HOBIT) Trial
Run by Hennepin Healthcare Research Institute · NCT02407028 · Data updated 2026-11-12
This study is testing different ways of using hyperbaric oxygen treatment to see if it can help people with severe brain injuries feel better.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 16 Years to 65 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Hennepin Healthcare Research Institute Academic / other |
| Locations | 11 sites (San Diego, California and 10 other locations) |
| Status | Recruiting |
| Started | June 25, 2018 |
| Main results expected | October 26, 2028 |
| Study ends | June 30, 2029 |
| Registry record updated | June 2, 2026 |
| Trial ID | NCT02407028 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 16 to 65 who present with severe TBI and meet specific clinical criteria.
✕Probably not a fit
Patients with pre-existing neurological diseases or those who cannot receive treatment within the specified time frame may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This phase II trial aims to identify the optimal parameters for hyperbaric oxygen (HBO2) treatment in patients with severe traumatic brain injury (TBI). The study will evaluate various combinations of pressure levels and the potential enhancement of treatment effectiveness through the use of non-breathing hyperbaric (NBH) techniques. By determining the most effective HBO2 treatment parameters, the trial seeks to provide critical data for a future definitive efficacy trial. The focus is on minimizing oxygen toxicity while maximizing therapeutic benefits for patients.
Why it matters
Potential benefit: If successful, this treatment could significantly improve recovery outcomes for patients with severe traumatic brain injury.
How similar studies have gone: Previous studies have indicated potential benefits of hyperbaric oxygen therapy in TBI, but this specific approach is novel and aims to refine treatment parameters.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 16 years or older and 65 years or younger * Present with severe TBI, defined as Glasgow Coma Scale (GCS) of 3 to 8. * Marshall computerized tomography (CT) score \>1 in patients with a GCS of 7 or 8 or patients with an alcohol level \>200 mg/dl * Ability to initiate the first hyperbaric oxygen treatment within 8 hours of admission in patients not requiring a craniotomy/craniectomy or any other major surgical procedure OR * Ability to initiate the first hyperbaric oxygen treatment within 14 hours of admission in patients requiring a craniotomy/craniectomy or major surgical procedure Exclusion Criteria: * First hyperbaric oxygen treatment cannot be initiated within 24 hours of injury * GCS of 3 with mid-position and non-reactive pupils bilaterally (4mm) * Penetrating head injury * Pregnant * Pre-existing neurologic disease (e.g. TBI or stroke or neurodegenerative disorder) with confounding residual neurologic deficits * Unstable acute spinal cord injury * Fixed coagulopathy * Severe hypoxia * Cardiopulmonary resuscitation performed * Coma suspected to de due to primarily non-TBI causes * Any contraindications to the study intervention
Where it's running
-
UCSD Medical Center - Hillcrest Hospital
San Diego, California, United States Recruiting -
St. Mary's Medical Center
West Palm Beach, Florida, United States Recruiting -
University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States Recruiting -
University of Kentucky Hospital
Lexington, Kentucky, United States Recruiting -
University of Maryland
Baltimore, Maryland, United States Recruiting -
Detroit Receiving Hospital
Detroit, Michigan, United States Recruiting
Show 5 more locations
-
Hennepin County Hospital
Minneapolis, Minnesota, United States Recruiting -
Duke University Hospital
Durham, North Carolina, United States Recruiting -
University of Nebraska Medical Center
Omaha, Nebraska, United States Completed -
The Ohio State University Wexner Medical Center
Columbus, Ohio, United States Completed -
Hamilton Heath Services
Hamilton, Ontario, Canada Completed
Study contacts
- Principal investigator: Gaylan L Rockswold, M.D., Ph.D. — Hennepin County Medical Center, Minneapolis
- Study coordinator: Gaylan L. Rockswold, M.D., Ph.D.
- Email: gaylan.rockswold@hcmed.org
- Phone: 612-873-2810
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PIONEER-Prognosis: Using biomarkers and wearables to forecast recovery after mild traumatic brain injury
This study tests whether blood biomarkers, health data from records, and wearables can help predict how people recover after a mild traumatic brain injury treated in the emergency department.
-
HBOT to see if it helps cognition and well‑being in first responders with prior brain injury
This study tests whether 40 hyperbaric oxygen therapy sessions can improve thinking skills and post-concussion symptoms in current or former first responders with a history of brain injury.
-
Depth Electrode Monitoring after Traumatic Brain Injury
This study tests adding a depth electrode with continuous brain monitoring during external ventricular drain placement in adults with traumatic brain injury to see if cortical reverberation signals can be tracked safely.
-
Understanding growth hormone deficiency after a brain injury in adults
This observational study tests whether growth hormone deficiency affects quality of life and symptoms in adults with traumatic brain injury and whether GH replacement helps after 12 weeks.
-
Electrical stimulation-assisted exercise for people with lower limb paralysis
This study tests whether adding electrical stimulation during exercise can improve leg muscle strength and endurance for people with paralysis.
-
ZEPU-2000 robotic rehab for arm and leg weakness
This trial tests whether adding ZEPU-2000A, ZEPU-2000D, and ZEPU-2000E robotic rehabilitation to usual therapy helps adults with arm/leg movement problems from stroke, incomplete SCI, TBI, or related conditions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.